SonoScape Medical Corp. (SHE:300633)

SonoScape Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,445	1,571	1,775	1,337	1,269	544.26
Trading Asset Securities	82.51	438.46	51.39	419.45	145.24	355.32
Cash & Short-Term Investments	1,528	2,009	1,826	1,757	1,415	899.58
Cash Growth	-22.19%	10.05%	3.95%	24.17%	57.27%	4.96%
Accounts Receivable	256.51	219.51	174.22	200.05	210.1	248.01
Other Receivables	20.46	23.82	18.73	22.67	43.94	14.73
Receivables	276.97	243.32	192.95	222.72	254.05	262.74
Inventory	760.27	653.08	531.48	514.38	440.52	310.7
Other Current Assets	80.36	69.13	74.96	20.55	22.98	18.12
Total Current Assets	2,646	2,975	2,625	2,514	2,132	1,491
Property, Plant & Equipment	940.27	936.34	719.89	594.55	482.68	323.15
Long-Term Investments	1.22	1.22	8.2	8.2	8.2	8.2
Goodwill	112.26	112.51	165.9	160.44	146.41	186.94
Other Intangible Assets	151	155.65	164.85	169.37	179.06	176.63
Long-Term Deferred Tax Assets	55.01	52.35	30.6	30.38	32.33	16.69
Long-Term Deferred Charges	34.49	35.13	17.93	13.75	4.75	7.84
Other Long-Term Assets	47.48	35.68	24.18	36.53	15.12	18.73
Total Assets	3,996	4,313	3,771	3,544	3,020	2,252
Accounts Payable	354.8	331.55	186.15	231.43	231.52	135.28
Accrued Expenses	95.11	259.09	245.28	181.94	174.72	152.99
Short-Term Debt	114.46	262.21	23.63	180.97	28.55	384.32
Current Portion of Long-Term Debt	15.22	0.02	-	-	-	19.38
Current Portion of Leases	-	16.57	14.81	10.83	12.88	-
Current Income Taxes Payable	6	0.58	2.08	4.68	5.58	3.55
Current Unearned Revenue	71.04	151.44	44.59	100.36	53.13	53.33
Other Current Liabilities	93.4	61.83	52.08	39.21	49.46	78.96
Total Current Liabilities	750.03	1,083	568.62	749.42	555.83	827.81
Long-Term Debt	40.02	40	-	-	43.32	43.18
Long-Term Leases	35.38	35.99	34.01	27.09	26	-
Long-Term Unearned Revenue	45.89	45.5	22.83	26.91	33.37	35.43
Long-Term Deferred Tax Liabilities	-	-	-	1.01	6.66	0.51
Total Liabilities	871.32	1,205	625.46	804.43	665.18	906.93
Common Stock	432.71	432.71	430.65	427.86	429.77	403.84
Additional Paid-In Capital	1,146	1,142	1,119	1,038	1,011	297.56
Retained Earnings	1,645	1,637	1,633	1,256	939.23	691.98
Treasury Stock	-120.03	-120.03	-59.99	-	-27.98	-55.98
Comprehensive Income & Other	20.68	16	23.78	18.57	2.72	7.6
Shareholders' Equity	3,125	3,108	3,146	2,740	2,355	1,345
Total Liabilities & Equity	3,996	4,313	3,771	3,544	3,020	2,252
Total Debt	205.08	354.79	72.44	218.89	110.74	446.88
Net Cash (Debt)	1,323	1,655	1,754	1,538	1,304	452.7
Net Cash Growth	-20.68%	-5.64%	14.03%	17.93%	188.04%	14.21%
Net Cash Per Share	3.06	3.83	4.05	3.58	3.27	1.17
Filing Date Shares Outstanding	429.82	429.82	429.41	427.86	429.77	403.84
Total Common Shares Outstanding	429.82	429.82	429.41	427.86	429.77	403.84
Working Capital	1,895	1,892	2,057	1,765	1,576	663.33
Book Value Per Share	7.27	7.23	7.33	6.40	5.48	3.33
Tangible Book Value	2,861	2,840	2,815	2,410	2,030	981.42
Tangible Book Value Per Share	6.66	6.61	6.56	5.63	4.72	2.43
Buildings	-	298.49	296.83	284.92	13.81	3.49
Machinery	-	361.58	249.19	183.14	162.61	154.17
Construction In Progress	-	393.94	254.2	181.3	373.39	255

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.